← All companies

BETR

BetterLife Pharma Inc.

BETRF OTC Pharmaceutical Preparations EDGAR ↗

$0.25

+0.07 +39.20%

Key statistics

from XBRL data in SEC filings

Market cap

$24.4M

Revenue (TTM)

—

Net income (TTM)

-$6.74M

EPS (TTM)

$-0.09

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$407K

Total assets

$7.08M

Gross margin

—

52-week range

$0.03 – $0.25

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jun 26, 2026 6-K FORM 6-K Jun 25, 2026 20-F FORM 20-F Jun 1, 2026 6-K FORM 6-K Apr 13, 2026 6-K FORM 6-K Sep 29, 2025 6-K FORM 6-K Jul 28, 2025 6-K FORM 6-K Jun 27, 2025 6-K FORM 6-K Jun 23, 2025 20-F FORM 20-F Jun 2, 2025 6-K FORM 6-K May 30, 2025 6-K FORM 6-K May 7, 2025 6-K FORM 6-K Apr 7, 2025 6-K FORM 6-K Dec 31, 2024 6-K FORM 6-K Dec 9, 2024 6-K FORM 6-K Oct 15, 2024 6-K FORM 6-K Sep 26, 2024 6-K FORM 6-K Aug 29, 2024 6-K FORM 6-K Aug 8, 2024 6-K FORM 6-K Jul 15, 2024 6-K FORM 6-K Jun 28, 2024 6-K FORM 6-K Jun 17, 2024 20-F FORM 20-F May 30, 2024 6-K FORM 6-K May 14, 2024 6-K FORM 6-K May 6, 2024 6-K FORM 6-K Apr 11, 2024 6-K FORM 6-K Apr 4, 2024 6-K FORM 6-K Mar 5, 2024 6-K FORM 6-K Jan 2, 2024 6-K FORM 6-K Dec 29, 2023 6-K FORM 6-K Dec 18, 2023 6-K FORM 6-K Nov 30, 2023 6-K FORM 6-K Sep 29, 2023 6-K FORM 6-K Sep 28, 2023 6-K FORM 6-K Sep 5, 2023 6-K FORM 6-K Jul 13, 2023 6-K FORM 6-K Jun 28, 2023 6-K FORM 6-K Jun 28, 2023 6-K FORM 6-K Jun 9, 2023 20-F/A FORM 20-F/A Jun 6, 2023 20-F FORM 20-F May 31, 2023